Swedish Orphan Biovitrum AB (FRA:B6E)
€ 23.86 -0.22 (-0.91%) Market Cap: 8.15 Bil Enterprise Value: 9.81 Bil PE Ratio: 42.61 PB Ratio: 2.56 GF Score: 89/100

Q1 2020 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript

Apr 29, 2020 / 11:00AM GMT
Release Date Price: €16.1 (-4.67%)
Operator

Ladies and gentlemen, welcome to the Sobi presentation of the Q1 results. (Operator Instructions)

I will now hand over to Guido Oelkers, CEO. Please go ahead.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Yes. Welcome, everybody. It's really a great pleasure to have you here on the Sobi call knowing that we are competing with quite another -- quite a few other earnings calls. So I go right into it. We'll start with the forward-looking statement as per usual, and please take note of this. And then I come to the presenters of today, this is Henrik, our CFO; and Milan, our Head of R&D, who will join me for this call.

And with this having said, these are obviously unprecedented times, so I go to Slide #4, and very challenging times. So before we talk about our very significant top line and -- top and bottom line growth, just wanted to tell you that we absolutely take this situation very seriously and take charge. So for us, the first priority was to make sure that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot